About This Event
Coya Therapeutics (Nasdaq: COYA), a clinical-stage biotechnology company developing multiple therapeutic programs intended to enhance Treg function, including biologics and cell therapies, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, CEO Dr. Howard Berman, rings the Closing Bell.